논문상세정보

' Standardized Pathology Report for Colorectal Cancer, 2nd Edition' 의 참고문헌

  • 위암 병리보고서 기재사항 표준화
    김우호 [2005]
  • 대장암 병리보고서 기재사항 표준화
    장희진 [2006]
  • Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
    Amado RG [2008]
  • Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer
  • What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
    김수희 [2016]
  • WHO classification of tumours: digestive system tumours
  • WHO classification of tumours of the digestive system
    Bosman FT [2010]
  • UK guidance for the pathological reporting of serrated lesions of the colorectum
    Bateman AC [2015]
  • Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer
    Wang LM [2009]
  • Tumor budding in colorectal carcinoma : time to take notice
    Mitrovic B [2012]
  • Tumor budding in colorectal cancer revisited : results of a multicenter interobserver study
    Koelzer VH [2015]
  • Traditional serrated adenomas(TSAs)admixed with other serrated(socalled precursor)polyps and conventional adenomas : a frequent occurrence
    Chetty R [2015]
  • Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
    Galon J [2014]
  • The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer
    Roxburgh CS [2012]
  • The importance of the pathologist’s role in assessment of the quality of the mesorectum
    Bosch SL [2012]
  • The current landscape of locally advanced rectal cancer
    Aklilu M [2011]
  • Sessile serrated adenomas with dysplasia : morphological patterns and correlations with MLH1 immunohistochemistry
    Liu C [2017]
  • Serrated pathway : alternative route to colorectal cancer
    Patai AV [2013]
  • Serrated lesions of the colorectum : review and recommendations from an expert panel
    Rex DK [2012]
  • Role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy : a pooled analysis from 2 randomized clinical trials
    Zaanan A [2018]
  • Risk factors for an adverse outcome in early invasive colorectal carcinoma
    Ueno H [2004]
  • Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer(Lynch syndrome)and microsatellite instability
    Umar A [2004]
  • Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference(ITBCC)2016
    Lugli A [2017]
  • Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
  • Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum, version 4.0.0.0
  • Prognostic value of BRAF and KRAS mutations in MSI and MSS stage III colon cancer
    Taieb J [2017]
  • Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy
    Rogers AC [2014]
  • Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinous adenocarcinoma
    Barresi V [2015]
  • Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer
    Dhadda AS [2011]
  • Prognostic factors in colorectal carcinomas arising in adenomas : implications for lesions removed by endoscopic polypectomy
    Haggitt RC [1985]
  • Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery
    Kang CM [2016]
  • Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab : a meta-analysis
  • Predicting lymph node metastasis in pT1 colorectal cancer : a systematic review of risk factors providing rationale for therapy decisions
    Bosch SL [2013]
  • Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor
    Saltz LB [2004]
  • Perineural invasion is an independent predictor of outcome in colorectal cancer
    Liebig C [2009]
  • Perineural invasion in cancer : a review of the literature
    Liebig C [2009]
  • Pathology of premalignant colorectal neoplasia
    Gibson JA [2016]
  • Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
    Ryan R [2005]
  • Pathological features of rectal cancer after preoperative radiochemotherapy
    Dworak O [1997]
  • Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma : clinicopathologic correlations
    Mandard AM [1994]
  • Panitumumab-FOLFOX4treatment and RAS mutations in colorectal cancer
  • PD-1 blockade in tumors with mismatch-repair deficiency
    Le DT [2015]
  • Outcome of acutely perforated colorectal cancers : experience of a single district general hospital
    Anwar MA [2006]
  • Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer(CheckMate 142) : an open-label, multicentre, phase 2 study
    Overman MJ [2017]
  • Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors
    Buhard O [2006]
  • Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer
  • Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour
    Nagtegaal I [2004]
  • Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes
  • Molecular determinants of cetuximab efficacy
  • Molecular biomarkers for the evaluation of colorectal cancer : guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
  • Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer
    Ogino S [2005]
  • Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
    Le DT [2017]
  • Microsatellite instability in the management of colorectal cancer
    Pino MS [2011]
  • Microsatellite instability in colorectal cancer
    Boland CR [2010]
  • Microsatellite instability as a marker of prognosis and response to therapy : a meta-analysis of colorectal cancer survival data
  • Microsatellite instability and colorectal cancer
  • Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2Stages and decreased survival time in TNM stages I and II
    Xu F [2009]
  • Management of early invasive colorectal cancer : risk of recurrence and clinical guidelines
    Kikuchi R [1995]
  • Locally advanced rectal cancer management: which role for the pathologist in 2011?
    Bibeau F [2011]
  • K-Ras mutation and prognosis of colorectal cancer : a meta-analysis
    Rui Y [2015]
  • Japanese Society for Cancer of the Colon and Rectum(JSCCR)guidelines 2016 for the treatment of colorectal cancer
    Watanabe T [2018]
  • Invasive micropapillary component and its clinico-histopathological significance in patients with colorectal cancer
  • Intramural and extramural vascular invasion in colorectal cancer : prognostic significance and quality of pathology reporting
    Betge J [2012]
  • Intramucosal colorectal carcinoma with invasion of the lamina propria : a study by the Japanese Society for Cancer of the Colon and Rectum
    Kojima M [2017]
  • Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer
    Giger OT [2012]
  • International classification of diseases for oncology (ICD-O). 3rd ed. 1st rev
  • Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability
    Mlecnik B [2016]
  • Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas : a prospective cohort study
    Choi DH [2009]
  • Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases
    Loes IM [2016]
  • Histologic features and cytologic techniques that aid pathologic stage assessment of colonic adenocarcinoma
  • Evaluation of the epidermal growth factor receptor(EGFR)in colorectal tumours and lymph node metastases
    McKay JA [2002]
  • Evaluation of histological regression grading systems in the neoadjuvant therapy of rectal cancer: do they have prognostic impact?
  • Evaluation of colorectal cancers for Lynch syndrome : practical molecular diagnostics for surgical pathologists
    Samowitz WS [2015]
  • Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer : a tissue microarray study
    Resnick MB [2004]
  • Epidermal growth factor receptor signaling in colorectal cancer : preclinical data and therapeutic perspectives
    Spano JP [2005]
  • Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma : implications for a standardized scoring system
  • ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
  • EGFR and colon cancer : a clinical view
  • EGFR Signaling in Colorectal Carcinoma
  • Degree of tumor regression after preoperative chemo-radiotherapy in locally advanced rectal cancer-Preliminary results
    Mihaylova I [2011]
  • Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
    Sargent DJ [2010]
  • Cytokeratinbased assessment of tumour budding in colorectal cancer : analysis in stage II patients and prospective diagnostic experience
    Koelzer VH [2017]
  • Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma : a Japanese collaborative study
    Kitajima K [2004]
  • Colorectal serrated adenocarcinoma
    Mäkinen MJ [2007]
  • Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cells
    Lee HJ [2013]
  • Colorectal cancer molecular biology moves into clinical practice
  • Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis
    Haupt B [2007]
  • Clinicopathological significance of microscopic abscess formation at the invasive margin of advanced low rectal cancer
    Uehara K [2007]
  • Clinicopathological and molecular characterization of colorectal micropapillary carcinoma
    Verdu M [2011]
  • Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation
    Smith KD [2010]
  • Carcinomas with micropapillary morphology : clinical significance and current concepts
    Nassar H [2004]
  • Cancer classification using the Immunoscore : a worldwide task force
    Galon J [2012]
  • BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair
    Wang L [2003]
  • BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
    Schirripa M [2015]
  • Association of Coloproctology of Great Britain & Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017)-pathology standards and datasets
    Langman G [2017]
  • Association between molecular subtypes of colorectal cancer and patient survival
    Phipps AI [2015]
  • Annual report of cancer statistics in Korea in 2015
  • An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers
    Goel A [2010]
  • AJCC cancer staging system
    Amin MB [2017]
  • A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome
    Adar T [2017]
  • A new prognostic classification of rectal cancer
    Jass JR [1987]
  • A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition : development of international criteria for the determination of microsatellite instability in colorectal cancer
    Boland CR [1998]